India to United States: Acarbose Export Trade Route
India has recorded 33 verified shipments of Acarbose exported to United States, representing a combined trade value of $3.1M USD. This corridor is served by 1 active Indian exporters, with an average shipment value of $95.3K USD. The leading Indian exporter is STRIDES PHARMA SCIENCE LIMITED, which accounts for 100% of total export value with 33 shipments worth $3.1M USD. On the buying side, STRIDES PHARMA INC is the largest importer in United States with $1.6M USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Acarbose corridor is one of India's established pharmaceutical export routes, with 33 shipments documented worth a combined $3.1M USD. The route is dominated by STRIDES PHARMA SCIENCE LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's acarbose manufacturing sector.
Across 1 active suppliers, the average shipment value stands at $95.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with acarbose's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 12.0%, placing it at rank #12 among India's top acarbose export destinations globally.
On the import side, key buyers of Indian acarbose in United States include STRIDES PHARMA INC, STRIDES PHARMA INC,. STRIDES PHARMA INC is the single largest importer with 14 shipments valued at $1.6M USD.
